In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...

GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not respond to levodopa, the main treatment for Parkinson's disease. Therefore, the ...

The Iowa Chapter of the American Parkinson Disease Association is holding a Parkinson education program from 1 to 3:30 p.m. Wednesday at the Fort Dodge Public Library, 424 Central Ave. The event is ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.